PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-06-12

Date Title Company
12-Jun-2023 Armis Identifies Riskiest OT and ICS Devices Across Critical Infrastructure Industries Businesswire
12-Jun-2023 Enveric Biosciences to Present at H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference Businesswire
12-Jun-2023 Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy Businesswire
12-Jun-2023 Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development Businesswire
12-Jun-2023 Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference Businesswire
12-Jun-2023 ONDEXXYA▼(ANDEXANET ALFA) PHASE IV TRIAL STOPPED EARLY AFTER ACHIEVING PRE-SPECIFIED CRITERIA ON HAEMOSTATIC EFFICACY VERSUS USUAL CARE AstraZeneca
12-Jun-2023 Quell Therapeutics Signs a Collaboration, Exclusive Option and License Agreement with AstraZeneca to Develop, Manufacture and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Quell Therapeutics
12-Jun-2023 Modus Therapeutics presented new data on sevuparin demonstrating its potential to treat anemia related to chronic diseases at the annual European Hematology Association Congress Modus Therapeutics
12-Jun-2023 Samsara Therapeutics unveils promising autophagy drug candidate, offering new hope for people with Parkinson's and motor neurone disease Samsara Therapeutics
12-Jun-2023 Bloomsbury Genetic Therapies Completes Successful Scientific Advice Meeting with the MHRA regarding its BGT-NPC Program Bloomsbury Genetic Therapies
12-Jun-2023 Autolomous and the Cell and Gene Therapy Catapult awarded £1.2m grant by UK Research and Innovation Autolomous
12-Jun-2023 Pioneering clinical trial service launched at PHTA University of Birmingham
12-Jun-2023 Babraham Research Campus announces new Board Appointment Babraham Research Campus
12-Jun-2023 UK-wide programme will encourage more people to consider giving the gift of life through living kidney donation Kidney Research UK
12-Jun-2023 Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma The Menarini Group
12-Jun-2023 BC Platforms Expands Data Partner Network with Major Brazilian Cardiovascular Health Institution BC Platforms
12-Jun-2023 Model N Named One of Fortune's 2023 Best Workplaces in the Bay Area Businesswire
12-Jun-2023 Futura's Fast-Acting Topical Gel for the Treatment of Erectile Dysfunction Granted Marketing Authorisation by the US FDA for Over the Counter Sale Futura Medical plc
12-Jun-2023 Syncona launches new gene therapy company Beacon Therapeutics with £96 million Series A financing Syncona
12-Jun-2023 REAL-WORLD RESULTS DEMONSTRATE HIGH RESPONSE RATE AND DURABLE REMISSION WITH KITE CAR T-CELL THERAPIES FOR R/R MCL AND FL AT EHA 2023 Kite